Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 353

    1.

    Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

    Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA, Eschwege E; DESIR Study Group.

    Diabetes Care. 2006 Jul;29(7):1619-25.PMID: 16801588 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.

    Ko GT, Chan JC, Yeung VT, Chow CC, Tsang LW, Li JK, So WY, Wai HP, Cockram CS.

    Diabetes Care. 1998 Aug;21(8):1221-5.PMID: 9702423 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Combined measurement of fasting plasma glucose and A1C is effective for the prediction of type 2 diabetes: the Kansai Healthcare Study.

    Sato KK, Hayashi T, Harita N, Yoneda T, Nakamura Y, Endo G, Kambe H.

    Diabetes Care. 2009 Apr;32(4):644-6. Epub 2009 Jan 8.PMID: 19131461 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers.

    Inoue K, Matsumoto M, Kobayashi Y.

    Diabetes Res Clin Pract. 2007 Sep;77(3):451-8. Epub 2007 Mar 7.PMID: 17346846 [PubMed - indexed for MEDLINE]Related articles

    6.

    Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes.

    Inoue K, Matsumoto M, Akimoto K.

    Diabet Med. 2008 Oct;25(10):1157-63.PMID: 19046193 [PubMed - indexed for MEDLINE]Related articles

    7.

    [What will be the proper criteria for impaired fasting glucose for Korean men? Based on medical screening data from a general hospital]

    Ryu S, Chang YS, Kim DI, Suh BS, Kim WS.

    J Prev Med Public Health. 2005 May;38(2):203-7. Korean. PMID: 16315759 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects.

    Ko GT, Chan JC, Tsang LW, Cockram CS.

    Diabetes Care. 2000 Dec;23(12):1770-3.PMID: 11128350 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.

    Jesudason DR, Dunstan K, Leong D, Wittert GA.

    Diabetes Care. 2003 Feb;26(2):485-90.PMID: 12547886 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).

    Perry RC, Shankar RR, Fineberg N, McGill J, Baron AD; Early Diabetes Intervention Program (EDIP).

    Diabetes Care. 2001 Mar;24(3):465-71.PMID: 11289469 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1C.

    Maynard JD, Rohrscheib M, Way JF, Nguyen CM, Ediger MN.

    Diabetes Care. 2007 May;30(5):1120-4. Epub 2007 Mar 2.PMID: 17337498 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Utility of hemoglobin A1c in predicting diabetes risk.

    Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ.

    J Gen Intern Med. 2004 Dec;19(12):1175-80.PMID: 15610327 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.

    Abdul-Ghani MA, Williams K, DeFronzo R, Stern M.

    Diabetes Care. 2006 Jul;29(7):1613-8.PMID: 16801587 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values.

    Woerle HJ, Pimenta WP, Meyer C, Gosmanov NR, Szoke E, Szombathy T, Mitrakou A, Gerich JE.

    Arch Intern Med. 2004 Aug 9-23;164(15):1627-32.PMID: 15302632 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM.

    Narayan KM, Hanson RL, Pettitt DJ, Bennett PH, Knowler WC.

    Diabetes Care. 1996 Sep;19(9):972-8.PMID: 8875091 [PubMed - indexed for MEDLINE]Related articles

    16.

    Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria.

    Davidson MB, Schriger DL, Peters AL, Lorber B.

    JAMA. 1999 Apr 7;281(13):1203-10. Erratum in: JAMA 1999 Jun 16;281(23):2187. PMID: 10199430 [PubMed - indexed for MEDLINE]Related articles

    17.

    Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects.

    Kuusisto J, Mykkänen L, Pyörälä K, Laakso M.

    Stroke. 1994 Jun;25(6):1157-64.PMID: 8202973 [PubMed - indexed for MEDLINE]Related articles

    18.

    Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation.

    Valderhaug TG, Jenssen T, Hartmann A, Midtvedt K, Holdaas H, Reisaeter AV, Hjelmesaeth J.

    Transplantation. 2009 Aug 15;88(3):429-34.PMID: 19667949 [PubMed - indexed for MEDLINE]Related articles

    19.

    Predictive risk factors for deterioration from normoglycemic state to type 2 diabetes mellitus or impaired glucose tolerance in a Tunisian urban population.

    Chihaoui M, Kanoun F, Ben Rehaiem B, Ben Brahim S, Ftouhi B, Mekaouar A, Fekih M, Mbazâd A, Zouari B, Ben Khalifa F.

    Diabetes Metab. 2001 Sep;27(4 Pt 1):487-95.PMID: 11547223 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    A simple way to estimate mean plasma glucose and to identify Type 2 diabetic subjects with poor glycaemic control when a standardized HbA1c assay is not available.

    Ozmen S, Cil T, Atay AE, Tuzcu AK, Bahceci M.

    Diabet Med. 2006 Oct;23(10):1151-4.PMID: 16978383 [PubMed - indexed for MEDLINE]Related articles